CompanyHeadlineTime (ET)
NVDANvidia CEO pushes back against report that his company's $100B OpenAI investment has stalled01/31 12:54
STELHalper Sadeh LLC Encourages STEL, GORO, SKYT Shareholders to Contact the Firm to Discuss Their Rights01/31 12:53
GEVGE Vernova's Q4 Was Strong—But the Backlog Number Matters More01/31 12:47
KLARROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Klarna Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - KLAR01/31 12:29
MSFTMicrosoft Shares Slide Despite Strong Cloud Growth. Is It Time to Buy the Dip?01/31 12:25
BAThe eVTOL Company No One Is Talking About (Hint: It's Not Joby Aviation or Archer)01/31 12:14
BAMHere's My Top Dividend Stock for 202601/31 12:07
IHGCan InterContinental Hotels Be the Leader of the Pack?01/31 12:01
PGPHFPhoenix Education Partners, Inc. Announcement: If You Have Suffered Losses in Phoenix Education Partners, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights01/31 12:00
AMDNvidia vs. AMD vs. Broadcom: What's the Best AI Chip Stock to Own for 202601/31 11:54
USARIs USA Rare Earth Stock a Once-in-a-Decade Rare-Earth Opportunity?​01/31 11:47
KOHere's How Many Shares of Coca-Cola You'd Need for $10,000 in Yearly Dividends01/31 11:31
OWLOWL DEADLINE MONDAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Blue Owl Capital Inc. Investors to Secure Counsel Before Important February 2 Deadline in Securities Class Action – OWL01/31 11:30
SPTMSPTM and VTI Both Offer Low-Cost Broad U.S Market Exposure, but Which Is the Better Buy?01/31 11:29
MU1 AI Stock I'm Buying Before It Goes Parabolic in 202601/31 11:12
OKYOOKYO Pharma's neuropathic corneal pain study greenlit by FDA - ICYMI01/31 11:03
SBUXStarbucks' Turnaround Strategy Drowned Out Strike Noise As U.S. Sales Rose 4%01/31 11:01
MELI$112 Million Vote of Confidence: This 12.8% Portfolio Bet Signals Conviction in MercadoLibre01/31 11:00
TSMIs It Too Late to Buy TSMC Stock After Its Run?01/31 11:00
WUWestern Union: Material Risk From Immigration Measures Outweighed By 5x Earnings Multiple01/31 10:58

Market News ×
Loading news…